Results 111 to 120 of about 13,707,731 (353)

Correlation between skin patch testing and clinical outcome in total knee arthroplasty, a serial prospective study. [PDF]

An Bras Dermatol, 2023
Tirico MCCP, Reis VMDS, Aoki V, Demange MK, Tirico LEP.   +4 more
europepmc   +1 more source

Influence of Ultraviolet Light on Patch Tests*

, 1965
A.H. Mohajerin, Stephan Epstein
openalex   +1 more source

Evaluation of an experimental patch test model for the detection of irritant skin reactions to moisturisers [PDF]

, 2000
Tove Agner, Elisabeth Held, Will West, John Gray   +3 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Trends in Patch Testing in the Medicare Part B Fee-for-Service Population. [PDF]

Dermatitis, 2022
Ravishankar A, Freese RL, Parsons HM, Warshaw EM, Goldfarb N.   +4 more
europepmc   +1 more source

Basophil Leukocytes in Non-vesicular Allergic Patch Test Reactions**From the Department of Dermatology, University of Lund, Lund, Sweden.Supported by a grant from the Alfred Österlund Foundation.

, 1963
Nils Aspergen, Sigfrid Fregert, Hans Rorsman   +2 more
openalex   +1 more source

Modulation of the atopy patch test reaction by topical corticosteroids and tar [PDF]

, 2000
Elisabeth G. Langeveld-Wildschut, Hannes Riedl, Theo Thepen, Ilse C. Biharia, P. L. B. Bruijnzeel, Carla A.F.M. Bruijnzeel-Koomen   +5 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Corrigendum: Patch Testing with Propolis of Different Geographical Origins in a Baseline Series. [PDF]

Acta Derm Venereol, 2022
Nyman GSA, Giménez-Arnau AM, Grigaitiene J, Malinauskiene L, Paulsen E, Hagvall L.   +5 more
europepmc   +1 more source

Allergy to wool fat. The addition of salicylic acid for patch test purposes.

, 1969
P Thune
openalex   +2 more sources